Your session is about to expire
← Back to Search
Behavioural Intervention
Smartphone-delivered CBT for SAD for Social Anxiety Disorder
N/A
Waitlist Available
Led By Sabine Wilhelm, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up endpoint (week 12)
Awards & highlights
Study Summary
This trial is testing whether a smartphone app can deliver effective treatment for social anxiety disorder.
Eligible Conditions
- Social Anxiety Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ endpoint (week 12)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint (week 12)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Difference in SAD severity (LSAS) at the end of treatment/waitlist period.
Secondary outcome measures
Difference in depression severity as assessed by change in The Center for Epidemiologic Studies Depression Scale - Revised (CESD-R) total scores from baseline to week 12.
Difference in functional impairment as measured by change in The Work and Social Adjustment Scale (WSAS) total scores from baseline to week 12.
Difference in quality of life as assessed by change in The Quality of Life, Enjoyment, and Satisfaction Questionnaire-Short Form (QLESQ-SR) total scores from baseline to week 12.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Experimental: Smartphone-delivered CBT for SADExperimental Treatment1 Intervention
12-week Smartphone delivered CBT for SAD.
Group II: 12 Week Waitlist ControlExperimental Treatment1 Intervention
12-week waitlist control. (Note: participants will be crossed over to 12-week Smartphone-delivered CBT for SAD following the 12-week waitlist control).
Find a Location
Who is running the clinical trial?
Koa Health B.V.Industry Sponsor
5 Previous Clinical Trials
420 Total Patients Enrolled
Massachusetts General HospitalLead Sponsor
2,918 Previous Clinical Trials
13,192,835 Total Patients Enrolled
Sabine Wilhelm, PhDPrincipal InvestigatorMassachusetts General Hospital
12 Previous Clinical Trials
921 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research project still open to enrolling participants?
"The latest records on clinicaltrials.gov indicate that the study, which initially began recruiting patients in September of 2023 and was last updated on April 6th 2022, is no longer actively enrolling participants. However, there are presently 416 other trials currently welcoming new enrollees."
Answered by AI
Who else is applying?
What state do they live in?
Alabama
Massachusetts
How old are they?
18 - 65
What site did they apply to?
Massachusetts General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger